CCMH
KERX

Cornerstone Capital Management Holdings’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$192K Buy
+41,500
New +$229K ﹤0.01% 1119
2015
Q2 		– Sell
-4,700
Closed -$60K – 1517
2015
Q1 		$60K Hold
4,700
– – ﹤0.01% 1302
2014
Q4 		$67K Sell
4,700
-11,600
-71% -$180K ﹤0.01% 1197
2014
Q3 		$224K Buy
16,300
+4,100
+34% +$62.8K ﹤0.01% 1088
2014
Q2 		$187K Buy
+12,200
New +$173K ﹤0.01% 1116
2013
Q4 		– Sell
-15,600
Closed -$157K – 1364
2013
Q3 		$157K Sell
15,600
-800
-5% -$7.12K ﹤0.01% 1085
2013
Q2 		$123K Buy
+16,400
New +$128K ﹤0.01% 1100

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cornerstone Capital Management Holdings's KERX Position: Q4 2017 in Review

Cornerstone Capital Management Holdings opened a new position in Keryx Biopharmaceuticals Inc (KERX) in Q4 2017: 41,500 shares worth $192K. The stake represents ﹤0.01% of the portfolio and ranks #1119 among its holdings. This is a return to the name: Cornerstone Capital Management Holdings previously reported a position in KERX as recently as Q1 2015.

Cornerstone Capital Management Holdings first reported a position in KERX in Q2 2013 and has held it in 7 quarters since. The position peaked at $224K in Q3 2014. 129 funds tracked by Wall St. Rank hold KERX as of Q4 2017.

  • Cornerstone Capital Management Holdings held 41,500 shares of Keryx Biopharmaceuticals Inc worth $192K as of Q4 2017.
  • Keryx Biopharmaceuticals Inc was a new Cornerstone Capital Management Holdings position in Q4 2017.
  • Keryx Biopharmaceuticals Inc made up ﹤0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #1119 holding.
  • Cornerstone Capital Management Holdings first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and has held it in 7 quarters since.
  • Cornerstone Capital Management Holdings's Keryx Biopharmaceuticals Inc position peaked at $224K in Q3 2014.
  • 129 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.